About the journal
JAPhA Pharmacotherapy is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,900 USD. Declared review time at DOAJ: 25 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2949-9623
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,900 USD
- Articles in DOAJ
- 26
- Declared review time
- 25 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/japha-pharmacotherapy
Index listings
- DOAJ · 2026-06-04
- Indexing
- DOAJ
- APC
- 1,900 USD
- Declared review time (DOAJ)
- 25 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
26
Most recent article
last month
Average review time (journal-declared via DOAJ)
25weeks
Works in OpenAlex
27
Last recorded publication year
2026
h-index
2
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy10
- Added to DOAJ
- 2026-06-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 93%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Intensive Care Unit Cognitive Disorders
- Intensive Care Unit Cognitive Disorders
- Academic Publishing and Open Access
- Anesthesia and Sedative Agents
Show all subjects (50)
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Anesthesia and Neurotoxicity Research
- Regulation of Appetite and Obesity
- Anesthesia and Neurotoxicity Research
- Academic Writing and Publishing
- Regulation of Appetite and Obesity
- Anesthesia and Sedative Agents
- Academic Writing and Publishing
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Academic Publishing and Open Access
- Ion Transport and Channel Regulation
- scientometrics and bibliometrics research
- Meta-analysis and systematic reviews
- Health Systems, Economic Evaluations, Quality of Life
- Bone Tissue Engineering Materials
- Cardiac electrophysiology and arrhythmias
- Lung Cancer Treatments and Mutations
- Heart Failure Treatment and Management
- Anesthesia and Pain Management
- Cancer Immunotherapy and Biomarkers
- Pharmaceutical Practices and Patient Outcomes
- Bone health and osteoporosis research
- Bariatric Surgery and Outcomes
- Diabetes Management and Education
- Pharmacogenetics and Drug Metabolism
- Ion Transport and Channel Regulation
- Estrogen and related hormone effects
- scientometrics and bibliometrics research
- Meta-analysis and systematic reviews
- Health Systems, Economic Evaluations, Quality of Life
- Bone Tissue Engineering Materials
- Heart Failure Treatment and Management
- Cardiac electrophysiology and arrhythmias
- Lung Cancer Treatments and Mutations
- Pharmaceutical Practices and Patient Outcomes
- Bariatric Surgery and Outcomes
- Bone health and osteoporosis research
- Cancer Immunotherapy and Biomarkers
- Anesthesia and Pain Management
- Diabetes Management and Education
- Pharmacogenetics and Drug Metabolism
- Estrogen and related hormone effects
Keywords (DOAJ)
- pharmacotherapy
- drug interactions
- clinical trials
- therapeutic agents
- pharmacokinetics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ